Company intelligence / Profile preview

QualTek Molecular Laboratories

Newtown, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

QualTek Molecular Laboratories was a Contract Research Organization (CRO) specializing in immunohistochemistry (IHC) services. It supported over 1,700 projects in research and clinical studies for pharmaceutical and biotechnology companies, with a strong focus on oncology and immuno-oncology, and developed a prototype PD-L1 companion diagnostic assay. The company was acquired by Discovery Life Sciences in 2019, integrating its team and capabilities.

Industry: Contract Research Organization

Beyond the preview

Go deeper on QualTek Molecular Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QualTek Molecular Laboratories.

Explore the full profile